Controlling Follicular NHL for Longer
RITUXAN can be used along with CVP chemotherapy as an initial treatment for follicular (indolent) NHL. And because they work to control NHL in different ways, RITUXAN and chemotherapy may work very well together. In fact, in one study (called Marcus), patients spent 1 year longer without their cancer advancing (compared with patients who received CVP chemotherapy by itself).
And 81% of patients who received RITUXAN plus CVP chemotherapy went into either partial or complete remission for a period of time.
Keep in mind: Remission can be partial or complete. Partial remission means the cancer is significantly improved, but evidence of the cancer remains. Complete remission means all evidence of the cancer is gone for a period of time.
How RITUXAN is given
- Along with CVP chemotherapy
- Every 3 weeks, for up to 8 infusions
The Marcus study
- Average patient age: 53 years
- 162 patients received RITUXAN plus CVP chemotherapy
- 160 patients received CVP chemotherapy by itself
- These previously untreated patients were in the later stages of disease
Important treatment considerations
- The most common side effects when RITUXAN was given with CVP chemotherapy were rash, cough, flushing, shaking, itching, low white blood cells, and chest tightness
- Please talk to your doctor about the potential benefits and risks of RITUXAN plus CVP chemotherapy